PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8807181-1	1996	PURPOSE: The bradycardia produced by neostigmine and edrophonium was examined according to its relation to cholinesterase inhibition and to its sensitivity to block by muscarinic receptor antagonists.	Edrophonium	53-64	butyrylcholinesterase	Felis catus	107-121	
8807181-12	1996	Edrophonium produced dose-dependent decreases in cholinesterase activity and heart rate, which were highly correlated (correlation coefficient r = 0.99, P < 0.0001).	Edrophonium	0-11	butyrylcholinesterase	Felis catus	49-63	
8807181-13	1996	The ED50 of the reduction in heart rate (0.9 +/- 0.18 mg.kg-1) and cholinesterase activity (0.89 +/- 0.12 mg.kg-1) produced by edrophonium were similar.	Edrophonium	127-138	butyrylcholinesterase	Felis catus	67-81	
8807181-14	1996	Moreover, the reduction in heart rate and cholinesterase activity produced by edrophonium reached a plateau at the same dose (6.4 mg.kg-1).	Edrophonium	78-89	butyrylcholinesterase	Felis catus	42-56